Integral Diagnostics Share Price and Company Fundamentals



Price
$2.32
Change
-0.020 (-0.855%)
52 week range
1.905 - 2.965

Last traded: Today at 6:10 AM

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, allied health professionals, and patients in Australia and New Zealand. It offers medical diagnostic imaging services, such as magnetic resonance imaging, computed tomography, mammography, ultrasound, and radiography, as well as nuclear medicine, including positron emission tomography. The company was founded in 1967 and is headquartered in East Melbourne, Australia.

Key Metrics

PE ratio

38.67

PB ratio

1.28

Dividend yield

4.01%

Beta

0.14

Market cap

$865.51M

Enterprise value

$1.42B

Company profile

Industry / Sector Diagnostics & Research / Healthcare
Full time employees 3049
Website https://www.integraldiagnostics.com.au
Mailing address 288 Victoria Parade Level 2 East Melbourne VIC 3002 Australia
Phone / Fax 61 3 5339 0704 / 61 3 9321 4926

Dividends

More: Integral Diagnostics Dividend history, yield and payout ratio

Dividend yield

4.01%

Dividend amount

$0.09

Payout ratio

125.86%

5Y Avg. yield

-%

Integral Diagnostics paid $0.09 dividend and the ex-dividend date was 28 Aug 2026.The dividend payout ratio is 125.86%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IDX dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.

Company Executives

As of Sep 2026, following are the company executives and directors listed on Integral Diagnostics.

Name Title Age Total Pay
Mr. Craig White Chief Financial Officer
Mr. Jason Martinez B.Com. MD, CEO & Director
Mr. Julian Gully Chief Information Officer
Ms. Melissa Wong Chief People Officer
Dr. Tony Chen Chief Medical Officer
Mr. John Merity B.A., L.L.B. Company Secretary

Profitability and management effectiveness

Profit margin

2.78%

Operating margin

10.26%

Return on assets

3.24%

Return on equity

3.21%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Integral Diagnostics is 865.51M and its enterprise value is 1.42B. The enterprise value to revenue ratio of IDX is 1.80. The enterprise value to EBITDA ratio of IDX is 12.66.

The IDX's stocks Beta value is 0.14 making it 86% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Integral Diagnostics (IDX)

Integral Diagnostics (ASX:IDX) Frequently Asked Questions

1. What is Integral Diagnostics's Stock Symbol?

Integral Diagnostics trades on ASX under the ticker symbol "IDX".

2. What is Integral Diagnostics's stock price today?

One share of IDX stock can currently be purchased for approximately $2.32.

3. How can I contact Integral Diagnostics?

Integral Diagnostics's mailing address is 288 Victoria Parade Level 2 East Melbourne VIC 3002 Australia. The company can be reached via phone at 61 3 5339 0704.

4. What is Integral Diagnostics's official website?

The official website of Integral Diagnostics is https://www.integraldiagnostics.com.au.